Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark. h/t Holger Zschaepitz
Our Twitter for Quick Updates: Twitter Follow Us
Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.